Skip to content

LSD's rapid antidepressant effects are modulated by 5-HT2B receptors.

Amel Bouloufa, Sarah Delcourte, Renaud Rovera, Thomas Delannay, Alizée Duquet, Lionel Moulédous, Ouria Dkhissi-Benyahya, Bruno P Guiard, Nasser Haddjeri

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie July 16, 2025 DOI: 10.1016/j.biopha.2025.118348 via PubMed

Summary

AI-generated from the abstract

Acute administration of LSD produces fast antidepressant- and anxiolytic-like effects in rats, along with hallucinatory-like effects and suppression of serotonin neuron activity. These effects are blocked by a selective 5-HT2B receptor antagonist, indicating they depend on activation of 5-HT2B receptors. Depletion of serotonin also prevents LSD's effects in the forced swim test and head-twitch response. In mice, LSD fails to produce antidepressant- or anxiolytic-like effects, and its hallucinogenic-like effect is not altered by 5-HT2B receptor blockade. The findings suggest LSD acts as a rapid-onset antidepressant in rats but not in mice, through mechanisms involving 5-HT2B receptor activation.

Study at a glance

Characteristics Experimental study Peer reviewed
Population Naive rats and naive mice
Intervention LSD
Duration Acute administration
Topics Depression LSD Serotonin
Keywords 5-ht2a Fast-acting antidepressants, 5-ht2b Hallucinogen
Citations 12
Key finding Acute LSD induces fast antidepressant- and anxiolytic-like effects in rats, but not in mice, through mechanisms involving activation of 5-HT2B receptors.

Abstract

Recent clinical trials show that serotonergic psychedelics, including the prototypical hallucinogen lysergic acid diethylamide (LSD), possess a great promise for treating affective disorders. Interestingly, LSD displays strong functional activity on 5-HT2B receptors and a modulatory role of the latter receptors in anxious and depressive-like behaviors has been reported. Using behavioral and in vivo electrophysiological tools in naive rats, the effects of acute administration of LSD were evaluated in the: forced swim test (FST), open field test, foot shock-induced ultrasonic vocalization, on the head-twitch response (HTR) and on the dorsal raphe serotonin 5-HT cell activity. By comparison, the antidepressant-, anxiolytic- and hallucinogenic-like effects of LSD were then assessed in naïve mice using the FST, the black & white box test and HTR. We show here that acute administration of LSD induced fast antidepressant-, anxiolytic- and hallucinatory-like effects as well as a suppression of 5-HT neuronal activity that were all counteracted by the selective pharmacological blockade of 5-HT2B receptors, including the potent and selective 5-HT2B receptors antagonist RS-127445. Interestingly, depletion of 5-HT prevented the action of LSD in FST and HTR. In contrast in mice, acute injection of LSD failed to produce an antidepressant- or anxiolytic-like response, and the hallucinogenic-like effect of LSD was not altered by a pretreatment with RS-127445. Together, these findings indicate that LSD, acutely administered, acts as a rapid-onset antidepressant in naïve rat, but not in naïve mice, through mechanisms involving activation of 5-HT2B receptors.

Explore topics

Comments

No comments yet.

Log in to comment